語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Impact of TRIPS in India[electronic ...
~
Malhotra, Prabodh, (1951-)
Impact of TRIPS in India[electronic resource] :an access to medicines perspective /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
338.4/761510954
書名/作者:
Impact of TRIPS in India : an access to medicines perspective // Prabodh Malhotra.
作者:
Malhotra, Prabodh,
出版者:
Basingstoke, Hampshire ; : Palgrave Macmillan,, 2010.
面頁冊數:
1 online resource (xxi, 320 p.) : : ill.
標題:
Pharmaceutical industry - India.
標題:
Pharmaceutical policy - India.
標題:
Health services accessibility - India.
標題:
Drug Industry - India.
標題:
Health Services Accessibility - India.
標題:
International Cooperation - India.
標題:
Patents as Topic - legislation & jurisprudence - India.
標題:
(1994)
標題:
Agreement on Trade-Related Aspects of Intellectual Property Rights.
標題:
Health services accessibility.
標題:
India.
標題:
Pharmaceutical industry.
標題:
Pharmaceutical policy.
標題:
BUSINESS & ECONOMICS - Industries
ISBN:
9780230290747 (electronic bk.)
ISBN:
0230290744 (electronic bk.)
書目註:
Includes bibliographical references and index.
內容註:
Foreword -- Acknowledgments -- Introduction -- PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES -- The World Trade Organization and the TRIPS Agreement -- The Global Pharmaceutical Industry and Developing New Drugs -- PART II: ACCESS TO MEDICINES IN INDIA -- Development of India's Pharmaceutical Industry -- TRIPS and the Indian Patents Regime -- Price Controls and Drug Affordability in India: Policy Options -- Health Insurance in India -- Broadening the Access to Medicines and Healthcare in India -- PART III: GLOBAL PERSPECTIVE -- Is TRIPS Appropriate for Developing Countries? -- Which Way Ahead? -- Final Conclusions -- References.
摘要、提要註:
Over the last three decades, drug prices in India have declined from one of the highest to one of the lowest in the world. Yet, under the current healthcare model, only around 35 per cent of people in India have access to medicines. In the lead up to 2005, when TRIPS compliant regime was introduced in India, there were apprehensions about the drug prices rising under the new regime, which would further restrict access to medicine. This book examines the impact of TRIPS on drug prices and exports of drugs and pharmaceuticals in India. It goes on to develop a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable, and can be replicated in other developing countries. This book is indispensable reading for all interested in development economics, intellectual property rights in developing countries, pharmaceutical markets and health systems.
電子資源:
An electronic book accessible through the World Wide Web; click for information
Impact of TRIPS in India[electronic resource] :an access to medicines perspective /
Malhotra, Prabodh,1951-
Impact of TRIPS in India
an access to medicines perspective /[electronic resource] :Prabodh Malhotra. - Basingstoke, Hampshire ;Palgrave Macmillan,2010. - 1 online resource (xxi, 320 p.) :ill.
Includes bibliographical references and index.
Foreword -- Acknowledgments -- Introduction -- PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES -- The World Trade Organization and the TRIPS Agreement -- The Global Pharmaceutical Industry and Developing New Drugs -- PART II: ACCESS TO MEDICINES IN INDIA -- Development of India's Pharmaceutical Industry -- TRIPS and the Indian Patents Regime -- Price Controls and Drug Affordability in India: Policy Options -- Health Insurance in India -- Broadening the Access to Medicines and Healthcare in India -- PART III: GLOBAL PERSPECTIVE -- Is TRIPS Appropriate for Developing Countries? -- Which Way Ahead? -- Final Conclusions -- References.
Over the last three decades, drug prices in India have declined from one of the highest to one of the lowest in the world. Yet, under the current healthcare model, only around 35 per cent of people in India have access to medicines. In the lead up to 2005, when TRIPS compliant regime was introduced in India, there were apprehensions about the drug prices rising under the new regime, which would further restrict access to medicine. This book examines the impact of TRIPS on drug prices and exports of drugs and pharmaceuticals in India. It goes on to develop a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable, and can be replicated in other developing countries. This book is indispensable reading for all interested in development economics, intellectual property rights in developing countries, pharmaceutical markets and health systems.
ISBN: 9780230290747 (electronic bk.)
Standard No.: 9786612997815
Source: 415111Palgrave Macmillanhttp://www.palgraveconnect.comSubjects--Uniform Titles:
Agreement on Trade-Related Aspects of Intellectual Property Rights
(1994)Subjects--Topical Terms:
522771
Pharmaceutical industry
--India.Index Terms--Genre/Form:
336502
Electronic books.
LC Class. No.: HD9672.I52 / M35 2010
Dewey Class. No.: 338.4/761510954
National Library of Medicine Call No.: 2010 M-470
Impact of TRIPS in India[electronic resource] :an access to medicines perspective /
LDR
:03652cam 2200481Ka 4500
001
387510
003
OCoLC
005
20130621114658.0
006
m o d
007
cr cn|||||||||
008
131001s2010 enka ob 001 0 eng d
019
$a
704277747
$a
707822113
$a
708566981
$a
763019625
020
$a
9780230290747 (electronic bk.)
020
$a
0230290744 (electronic bk.)
020
$z
9780230272781
020
$z
0230272789
024
8
$a
9786612997815
029
1
$a
AU@
$b
000046932678
035
$a
(OCoLC)696332299
$z
(OCoLC)704277747
$z
(OCoLC)707822113
$z
(OCoLC)708566981
$z
(OCoLC)763019625
035
$a
ocn696332299
037
$a
415111
$b
Palgrave Macmillan
$n
http://www.palgraveconnect.com
040
$a
UKPGM
$b
eng
$c
UKPGM
$d
EBLCP
$d
N$T
$d
OCLCQ
$d
YDXCP
$d
OCLCQ
$d
CDX
$d
E7B
$d
OCLCE
$d
OCLCQ
043
$a
a-ii---
049
$a
TEFA
050
4
$a
HD9672.I52
$b
M35 2010
060
4
$a
2010 M-470
060
4
$a
QV 736
072
7
$a
BUS
$x
070130
$2
bisacsh
082
0 4
$a
338.4/761510954
$2
22
100
1
$a
Malhotra, Prabodh,
$d
1951-
$3
522770
245
1 0
$a
Impact of TRIPS in India
$h
[electronic resource] :
$b
an access to medicines perspective /
$c
Prabodh Malhotra.
260
$a
Basingstoke, Hampshire ;
$a
New York :
$b
Palgrave Macmillan,
$c
2010.
300
$a
1 online resource (xxi, 320 p.) :
$b
ill.
504
$a
Includes bibliographical references and index.
505
0
$a
Foreword -- Acknowledgments -- Introduction -- PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES -- The World Trade Organization and the TRIPS Agreement -- The Global Pharmaceutical Industry and Developing New Drugs -- PART II: ACCESS TO MEDICINES IN INDIA -- Development of India's Pharmaceutical Industry -- TRIPS and the Indian Patents Regime -- Price Controls and Drug Affordability in India: Policy Options -- Health Insurance in India -- Broadening the Access to Medicines and Healthcare in India -- PART III: GLOBAL PERSPECTIVE -- Is TRIPS Appropriate for Developing Countries? -- Which Way Ahead? -- Final Conclusions -- References.
520
$a
Over the last three decades, drug prices in India have declined from one of the highest to one of the lowest in the world. Yet, under the current healthcare model, only around 35 per cent of people in India have access to medicines. In the lead up to 2005, when TRIPS compliant regime was introduced in India, there were apprehensions about the drug prices rising under the new regime, which would further restrict access to medicine. This book examines the impact of TRIPS on drug prices and exports of drugs and pharmaceuticals in India. It goes on to develop a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable, and can be replicated in other developing countries. This book is indispensable reading for all interested in development economics, intellectual property rights in developing countries, pharmaceutical markets and health systems.
588
$a
Description based on print version record.
630
0 0
$a
Agreement on Trade-Related Aspects of Intellectual Property Rights
$d
(1994)
$3
522781
650
0
$a
Pharmaceutical industry
$z
India.
$3
522771
650
0
$a
Pharmaceutical policy
$z
India.
$3
522772
650
0
$a
Health services accessibility
$z
India.
$3
522773
650
1 2
$a
Drug Industry
$z
India.
$3
522774
650
2 2
$a
Health Services Accessibility
$z
India.
$3
522775
650
2 2
$a
International Cooperation
$z
India.
$3
522776
650
2 2
$a
Patents as Topic
$x
legislation & jurisprudence
$z
India.
$3
522777
650
4
$a
(1994)
$3
522778
650
4
$a
Agreement on Trade-Related Aspects of Intellectual Property Rights.
$3
522779
650
4
$a
Health services accessibility.
$3
425879
650
4
$a
India.
$3
522543
650
4
$a
Pharmaceutical industry.
$3
376576
650
4
$a
Pharmaceutical policy.
$3
376574
650
7
$a
BUSINESS & ECONOMICS
$x
Industries
$x
Pharmaceutical & Biotechnology.
$2
bisacsh
$3
522780
655
4
$a
Electronic books.
$2
local
$3
336502
710
2
$a
Palgrave Connect (Online service)
$3
370384
776
0 8
$i
Print version:
$a
Malhotra, Prabodh, 1951-
$t
Impact of TRIPS in India.
$d
Basingstoke, Hampshire ; New York : Palgrave Macmillan, 2010
$z
9780230272781
$w
(DLC) 2010027535
$w
(OCoLC)635463615
856
4 0
$3
Palgrave Connect
$u
http://www.palgraveconnect.com/doifinder/10.1057/9780230290747
$z
An electronic book accessible through the World Wide Web; click for information
938
$a
EBL - Ebook Library
$b
EBLB
$n
EBL652442
938
$a
YBP Library Services
$b
YANK
$n
3615021
938
$a
Coutts Information Services
$b
COUT
$n
17388964
$c
65.00 GBP
938
$a
ebrary
$b
EBRY
$n
ebr10445686
938
$a
EBSCOhost
$b
EBSC
$n
356660
994
$a
C0
$b
TEF
筆 0 讀者評論
多媒體
多媒體檔案
http://www.palgraveconnect.com/doifinder/10.1057/9780230290747
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入